Komori
Japan Medical Dynamic Marketing (7600) · InitiativeRestated

COVID-19 Infection Prevention and Business Continuity Measures

First written in FY2020. 1 of 3 entries say "Advanced", first in FY2021-Q2. Latest entry: FY2024.

3entries
5years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseAdvancedFY2021-Q22020: 220202021: 020212022: 020222023: 020232024: 12024
Same theme, other companies
Response to COVID-19 and Transformation of Work StylesA theme 696 companies write about · 198 as a headwind · 461 as a tailwind

The whole theme swung hardest in 2026: 2 of 7 companies on the "Worse" side.

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 200 companies compared. The sentences above are computed from all 200.Comparing 200 of the theme's 699 threads.
Full recordFilings, disclosures and news, newest first
  1. FY2024RestatedAnnual report

    「When infectious diseases spread, the Company places the safety of its customers, business partners, employees and their families first. In accordance with health-administration guidelines in each country, it will thoroughly implement infection-prevention measures such as mask wearing and avoiding the 3 Cs (closed spaces, crowded places and close-contact settings), in principle prohibit travel and business trips to countries and regions with high infection risks, suspend or postpone events and hold them remotely where appropriate, and implement telework, including working from home, mainly in administrative departments, in an effort to prevent further spread of infection.」

    The policy of using measures such as mask wearing, avoiding the 3 Cs, business-trip restrictions, remote events and telework when infectious diseases spread remains in place.
  2. FY2021-Q2AdvancedAnnual report

    「However, we expect the conditions seen in the first half, when sales activities were severely restricted by limits on access to medical institutions because of the impact of COVID-19 and Education programs, medical conferences and seminars were cancelled, to continue in the second half. It remains difficult to explain new implants and surgical instruments to healthcare professionals in person and allow them to handle the products, and the sales-expansion effect of introducing new products in the second half is expected to fall below the initial outlook. The sales-expansion effect from expanding the customer base is also expected to fall below the initial outlook because medical institutions have restricted in-person sales activities to acquire new customers. However, in addition to introducing products as scheduled, we will work to actively expand seminars and study sessions conducted remotely and further strengthen remote sales activities.」

    With in-person sales activities and education programs and seminars restricted, the policy of strengthening remote seminars, study sessions and sales activities in the second half has been specified.
  3. FY2020First statedAnnual report

    「The Company places the safety of its customers, business partners, employees and their families first. To prevent further spread of infection, it has thoroughly implemented infection-prevention measures in accordance with health-administration guidelines in each country, including mask wearing and avoiding the 3 Cs (closed spaces, crowded places and close-contact settings); in principle, it prohibits travel and business trips to countries and regions with high infection risks; suspends or postpones events attended by large numbers of visitors; and implements telework, including working from home, mainly in administrative departments, thereby working to reduce risks.」

    Specific COVID-19 infection-prevention and business-continuity measures, including mask wearing, avoiding the 3 Cs, travel and business-trip restrictions, event suspensions and postponements, and telework, have been consolidated and disclosed for the first time.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
Japan Medical Dynamic Marketing's next results are scheduled for 2026-11-04. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
COVID-19 Infection Prevention and Business Continuity Measures | Japan Medical Dynamic Marketing,INC. (7600) | Komori